CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $30,370
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-06 | Kuznik Paul Brian Director | Grant or award · Stock Options (right to buy) | +125,000 | 125,000 | ||
| 2026-10-06 | COWARD D SCOTT Director | Grant or award · Stock Options (right to buy) | +125,000 | 125,000 | ||
| 2026-09-14 | Jones Keith Anthony Director | Purchase | +10,000 | $0.56 | $6K | 50,000 |
| 2026-08-20 | Jones Keith Anthony Director | Purchase | +10,000 | $0.69 | $7K | 40,000 |
| 2026-08-17 | Jones Keith Anthony Director | Purchase | +30,000 | $0.59 | $18K | 30,000 |
| 2026-06-11 | Windham-Bannister Susan Richards Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Constantino Michael T. Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Wallace Max N. Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Sebelius Kathleen Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Jones Keith Anthony Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Green Charles Bruce Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Seimetz Diane Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Bamforth John Philip Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Brown Emery N. Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2026-06-11 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +0 | 0 | ||
| 2026-05-19 | Sebelius Kathleen Director | Purchase | +56,818 | $0.88 | $50K | 148,025 |
| 2026-05-18 | Parikh Shamik J Chief Medical Officer | Sale 10b5-1 | −45,887 | $0.90 | $41K | 272,713 |
| 2026-05-18 | Sander Dale A. CFO and Chief Corp. Dev. Off | Sale 10b5-1 | −45,887 | $0.90 | $41K | 267,213 |
| 2026-05-18 | Constantino Michael T. Director | Purchase | +11,000 | $0.89 | $10K | 43,950 |
Page 1 of 17 · 330 trades